Nimewo CAS 1380575-43-8|LDK-378 Dihydrochloride

Entwodiksyonak aplikasyon nan Nimewo CAS 1380575-43-8|LDK-378 dikloridrat

LDK-378 dihydrochloridese yon molekil ki itilize nan tretman kansè. Li inibit tirozin kinaz, ki se anzim ki enplike nan siyal selil ak kwasans.LDK-378 dihydrochlorideyo te montre yo efikas kont kansè ki te devlope rezistans nan lòt tretman, tankou butyrate, chloroformate, nitro, ak asid idroklorik. Yo te montre li anpeche pwodiksyon espès oksijèn reyaktif ak faktè necrosis timè- (TNF-) nan modèl sourit ak kansè nan poumon. Dòz efikas ceritinib dihydrochloride poko konnen.

Sinonim:

Ceritinib dihydrochloride;

LDK378 (Ceritinib) dihydrochloride;

LDK378dihydrochloride;

LDK378 (dihydrochloride);

LDK3782Hcl;

Ceritinibdihydrochloride;

5-kloro-N2-(2-izopropoxy-5-Methyl-4-(piperidin{-4-il)fenil)-N4-( 2-(izopropylsulfonyl)phenyl)piriMidine-2,4-diaMinehydrochloride;

LDK378dihydrochloride,Ceritinibdihydrochloride

Spesifikasyon nan Nimewo CAS 1380575-43-8|LDK-378 dikloridrat

Pake ak transpònan Entwodiksyon ak aplikasyon nanNimewo CAS 1380575-43-8|LDK-378 dikloridrat

Pake: 0.1g,1g,5g,25g,100g,500g,1kg

Transpò: pa courrier / pa lè / pa lanmè

Baj popilè: ka non.1380575-43-8|ldk-378 dihydrochloride, Lachin cas non.1380575-43-8|ldk-378 dihydrochloride manifakti yo, faktori